Drug Type Small molecule drug |
Synonyms KRP 104 |
Target |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H26FN3O3 |
InChIKeyAKFNKZFJBFQFAA-DIOPXHOYSA-N |
CAS Registry862501-61-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | US | 01 Oct 2009 | |
Diabetes Mellitus, Type 2 | Phase 2 | AR | 01 Oct 2009 | |
Diabetes Mellitus, Type 2 | Phase 2 | CZ | 01 Oct 2009 | |
Diabetes Mellitus, Type 2 | Phase 2 | GT | 01 Oct 2009 | |
Diabetes Mellitus, Type 2 | Phase 2 | PL | 01 Oct 2009 | |
Diabetes Mellitus, Type 2 | Phase 2 | RU | 01 Oct 2009 | |
Diabetes Mellitus, Type 2 | Phase 2 | ZA | 01 Oct 2009 |
Phase 2 | 403 | Placebo | qluzssckek(cziwxofsgf) = vjkpgposyx vttshtoukh (qphpsvgnnj, zuakwgduvq - cddxizdwjx) View more | - | 26 Jun 2014 | ||
Phase 1/2 | - | xetkjirxyc(azpqrqnjsd) = ftwwgwklhw mpnjdprovq (xbsebrhsqg ) | Positive | 03 Oct 2012 | |||
zgzcxikghe(mdmfxaitiz) = olenqiwmqe dgqopcrhjc (cqioxtbnzi ) |